D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 88 Citations 23,758 326 World Ranking 8513 National Ranking 4548

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Gene
  • Cancer

Anna Csiszar mainly investigates Internal medicine, Oxidative stress, Endocrinology, Endothelium and Inflammation. Her Internal medicine study typically links adjacent topics like Apoptosis. The various areas that Anna Csiszar examines in her Oxidative stress study include Reactive oxygen species, Senescence, Endothelial dysfunction, Resveratrol and Mitochondrion.

Her Endocrinology research includes themes of Proinflammatory cytokine and Cell biology. Her study in the fields of Endothelial activation under the domain of Endothelium overlaps with other disciplines such as Bone morphogenetic protein 2. Her biological study spans a wide range of topics, including Phenotype, Cholesterol, Bioinformatics and Pulse wave velocity.

Her most cited work include:

  • Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. (938 citations)
  • Aging-Induced Phenotypic Changes and Oxidative Stress Impair Coronary Arteriolar Function (457 citations)
  • Mechanisms of vascular aging: new perspectives. (381 citations)

What are the main themes of her work throughout her whole career to date?

Anna Csiszar focuses on Internal medicine, Endocrinology, Oxidative stress, Senescence and Endothelial dysfunction. Her work in Internal medicine covers topics such as Cardiology which are related to areas like Dementia. She has researched Endocrinology in several fields, including Proinflammatory cytokine, Apoptosis, Cerebral arteries and Downregulation and upregulation.

Her research in Oxidative stress intersects with topics in Inflammation, Immunology, Reactive oxygen species, Endothelium and Resveratrol. Her Senescence study integrates concerns from other disciplines, such as Geroscience, Homeostasis and Ageing. The Endothelial dysfunction study combines topics in areas such as NAD+ kinase and Vasodilation.

She most often published in these fields:

  • Internal medicine (60.92%)
  • Endocrinology (45.69%)
  • Oxidative stress (41.67%)

What were the highlights of her more recent work (between 2018-2021)?

  • Senescence (27.59%)
  • Internal medicine (60.92%)
  • Cognitive decline (23.85%)

In recent papers she was focusing on the following fields of study:

Anna Csiszar mostly deals with Senescence, Internal medicine, Cognitive decline, Endothelial dysfunction and Oxidative stress. Her studies in Senescence integrate themes in fields like Homeostasis and Bioinformatics. Her research integrates issues of Endocrinology and Cardiology in her study of Internal medicine.

Her Cognitive decline research incorporates themes from Neuroinflammation, Stimulation, Neuroscience, Pharmacology and Cerebral blood flow. Her study looks at the intersection of Endothelial dysfunction and topics like Vasodilation with Cell migration and Angiogenesis. Her Oxidative stress study combines topics from a wide range of disciplines, such as Reactive oxygen species, Microcirculation and Endothelium.

Between 2018 and 2021, her most popular works were:

  • Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice. (63 citations)
  • Nicotinamide mononucleotide (NMN) treatment attenuates oxidative stress and rescues angiogenic capacity in aged cerebromicrovascular endothelial cells: a potential mechanism for the prevention of vascular cognitive impairment. (41 citations)
  • Nicotinamide mononucleotide (NMN) treatment attenuates oxidative stress and rescues angiogenic capacity in aged cerebromicrovascular endothelial cells: a potential mechanism for the prevention of vascular cognitive impairment. (41 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cancer

The scientist’s investigation covers issues in Senescence, NAD+ kinase, Oxidative stress, Endothelial dysfunction and Cognitive decline. Her Senescence research includes elements of Pharmacology and Homeostasis. Her Oxidative stress research incorporates elements of Reactive oxygen species, Microcirculation and Pathogenesis.

Her Endothelial dysfunction research is classified as research in Internal medicine. Her Internal medicine study incorporates themes from Effects of sleep deprivation on cognitive performance and Cardiology. Her Cognitive decline research integrates issues from Inflammation, Stimulation, Cerebral blood flow and Synaptic plasticity.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span.

Kevin J. Pearson;Joseph A. Baur;Kaitlyn N. Lewis;Leonid Peshkin.
Cell Metabolism (2008)

1276 Citations

Aging-Induced Phenotypic Changes and Oxidative Stress Impair Coronary Arteriolar Function

Anna Csiszar;Zoltan Ungvari;John G. Edwards;Pawel Kaminski.
Circulation Research (2002)

635 Citations

Mechanisms of vascular aging: new perspectives.

Zoltan Ungvari;Gabor Kaley;Rafael de Cabo;William E. Sonntag.
Journals of Gerontology Series A-biological Sciences and Medical Sciences (2010)

579 Citations

Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.

Zoltan I Ungvari;Zsolt Bagi;Attila Feher;Fabio A. Recchia.
American Journal of Physiology-heart and Circulatory Physiology (2010)

547 Citations

What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol

Ole Vang;Nihal Ahmad;Clifton A. Baile;Joseph A. Baur.
PLOS ONE (2011)

509 Citations

Inflammation and endothelial dysfunction during aging: role of NF-κB

Anna Csiszar;Mingyi Wang;Edward G Lakatta;Zoltan I Ungvari.
Journal of Applied Physiology (2008)

491 Citations

Resveratrol induces mitochondrial biogenesis in endothelial cells.

Anna Csiszar;Nazar Labinskyy;John T Pinto;Praveen Ballabh.
American Journal of Physiology-heart and Circulatory Physiology (2009)

448 Citations

Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells

Zoltan I Ungvari;Zoltan I Ungvari;Nazar Labinskyy;Partha Mukhopadhyay;John T Pinto.
American Journal of Physiology-heart and Circulatory Physiology (2009)

367 Citations

Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging

Peter Toth;Stefano Tarantini;Anna Csiszar;Anna Csiszar;Zoltan I Ungvari.
American Journal of Physiology-heart and Circulatory Physiology (2017)

366 Citations

Increased mitochondrial H2O2 production promotes endothelial NF-κB activation in aged rat arteries

Zoltan Ungvari;Zsuzsanna Orosz;Nazar Labinskyy;Aracelie Rivera.
American Journal of Physiology-heart and Circulatory Physiology (2007)

343 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Anna Csiszar

Rafael de Cabo

Rafael de Cabo

National Institutes of Health

Publications: 67

Akos Koller

Akos Koller

New York Medical College

Publications: 66

David A. Sinclair

David A. Sinclair

Harvard University

Publications: 53

Pal Pacher

Pal Pacher

National Institutes of Health

Publications: 50

Douglas R. Seals

Douglas R. Seals

University of Colorado Boulder

Publications: 50

Zoltan Ungvari

Zoltan Ungvari

University of Oklahoma Health Sciences Center

Publications: 34

Edward G. Lakatta

Edward G. Lakatta

National Institutes of Health

Publications: 32

Rochelle Buffenstein

Rochelle Buffenstein

The University of Texas Health Science Center at San Antonio

Publications: 25

Frank M. Faraci

Frank M. Faraci

University of Iowa

Publications: 24

Joseph A. Baur

Joseph A. Baur

University of Pennsylvania

Publications: 23

Johan Auwerx

Johan Auwerx

École Polytechnique Fédérale de Lausanne

Publications: 21

Csaba Szabó

Csaba Szabó

University of Fribourg

Publications: 21

Daniel Henrion

Daniel Henrion

University of Angers

Publications: 19

Andrzej Bartke

Andrzej Bartke

Southern Illinois University School of Medicine

Publications: 19

Michael S. Wolin

Michael S. Wolin

New York Medical College

Publications: 17

Peter Stenvinkel

Peter Stenvinkel

Karolinska Institute

Publications: 17

Trending Scientists

Roberto Battiti

Roberto Battiti

University of Trento

Jacques Desrosiers

Jacques Desrosiers

HEC Montréal

Yann Bugeaud

Yann Bugeaud

University of Strasbourg

Xiaoning Jiang

Xiaoning Jiang

North Carolina State University

H. Eric Xu

H. Eric Xu

Chinese Academy of Sciences

Peter N. Robinson

Peter N. Robinson

University of Connecticut

Spencer M. Whitney

Spencer M. Whitney

Australian National University

Guido Flamini

Guido Flamini

University of Pisa

Jan Pohl

Jan Pohl

Centers for Disease Control and Prevention

Luca M. Neri

Luca M. Neri

University of Ferrara

Adolphe Nicolas

Adolphe Nicolas

University of Montpellier

Sergey Malyshev

Sergey Malyshev

Geophysical Fluid Dynamics Laboratory

Tristram O. West

Tristram O. West

Oak Ridge National Laboratory

Bettina Pollok

Bettina Pollok

Heinrich Heine University Düsseldorf

Srinivasa Vittal Katikireddi

Srinivasa Vittal Katikireddi

University of Glasgow

Allan Collins

Allan Collins

Northwestern University

Something went wrong. Please try again later.